Search Orphan Drug Designations and Approvals
-
Generic Name: | Coagulation factor IX | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Mononine | ||||||||||||||||
Date Designated: | 06/27/1989 | ||||||||||||||||
Orphan Designation: | Replacement treatment and prophylaxis of the hemorrhagic complications of hemophilia B. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Armour Pharmaceutical Company 500 Arcola Road, P.O. Box 1200 Collegeville, Pennsylvania 19426 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Coagulation factor IX |
---|---|---|
Trade Name: | Mononine | |
Marketing Approval Date: | 08/20/1992 | |
Approved Labeled Indication: | Prevention and control of bleeding in factor IX deficiency, also known as hemophilia B or Christmas disease. | |
Exclusivity End Date: | 08/20/1999 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-